OsteoCool 2.0 bone tumor ablation system
Search documents
Tumor Ablation Market Research Report 2025-2032 | Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments
GlobeNewswire News Roomยท 2025-07-18 11:02
Core Insights - The global tumor ablation market is projected to grow from US$ 1.67 billion in 2024 to US$ 4.15 billion by 2032, indicating a significant growth trajectory [1]. By Technology - Radiofrequency ablation holds the largest revenue share in the tumor ablation market due to its specificity and efficiency in treating solid tumors in the liver, lung, and kidney [7]. - Microwave ablation technology is expected to experience the fastest growth, as it is effective in tissues with low electrical conductance [7]. - Cryoablation is gaining traction for treating tumors in the liver, kidneys, and prostate [7]. - High-intensity focused ultrasound (HIFU) and irreversible electroporation (IRE) are emerging modalities, with IRE being a minimally invasive outpatient procedure [7]. By Treatment Mode - Percutaneous ablation is the dominant treatment mode, offering faster recovery and minimal scarring [7]. - Surgical ablation remains a conventional and effective method for various tumor types [7]. - Laparoscopic ablation is anticipated to grow rapidly due to its precision in complex cases [7]. By Application - The liver cancer segment accounted for over 21% of the market share in 2024, driven by the high prevalence of liver cancer and a preference for minimally invasive treatments [7]. - Kidney cancer also holds a substantial market share, supported by the increasing prevalence and adoption of minimally invasive treatments [7]. - Prostate cancer and bone cancer are competing for significant shares in the tumor ablation market [8]. By End-User - Hospitals are the largest end-user segment due to their comprehensive healthcare services [14]. - Oncology centers also represent a significant share, focusing exclusively on cancer care with advanced technologies [14]. By Region - North America leads the tumor ablation market, supported by high healthcare expenditure and advanced medical technologies [14]. - Europe is the second-largest market, driven by an aging population and rising cancer prevalence [14]. - The Asia Pacific region is expected to grow the fastest, with emerging economies like China and India presenting untapped opportunities [14].